Unit 2: Standard Operating Procedures (SOPs): The Blueprint for Safety and Excellence

The session will focus on the critical role the designated person plays in ensuring that Standard Operating Procedures (SOPs) are both appropriate and effectively implemented within sterile compounding environments. Participants will explore the importance of reviewing SOPs upon development and at least annually to confirm alignment with current practices. The session will also emphasize best practices for documenting revisions and communicating changes to all affected personnel. By the conclusion, learners will have a clear understanding of their responsibilities in managing and maintaining SOPs to promote safety, compliance, and excellence in sterile compounding operations.

Learning Objectives:

  1. Specify when an SOP is required accorrding to USP <797>.
  2. Describe how the designated person is involved in SOP development and oversight.
  3. Develop examples of SOPs that are effective and meet regulatory requirements. 
  4. Established processes to review SOPs to ensure they reflect current practices and regulatory requirements. 

Barbara Petroff, MS, RPh, FASHP, BCSCP, FNHIA, CAC, CSPP, IgCP

Principal

Shawler Petroff LLC

Barbara Petroff is a graduate of Ohio State University College of Pharmacy. She completed a Master's Degree in Administration at Central Michigan University. After starting her career in research in Product Development specializing in sterile products she worked for several years in hospital pharmacy before turning to home infusion where she has been for over 30 years. In addition she was a surveyor for the ACHC for 23 years, taught Healthcare Management at University of Phoenix, was adjunct faculty for five schools of pharmacy and currently teaches a pharmacy technician training class. She has been a member of ASHP for many years serving on several committees. She was on the Executive Committee for the Section of Ambulatory Care Practitioners and served as the Chair of the Home Infusion Section Advisory Group.  She has been a member of NHIA and currently serves as the chair of the Sterile Compounding Practice Committee.

NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

Barbara Petroff has no relevant financial relationships with ineligible companies to disclose.

Key:

Complete
Failed
Available
Locked
Unit 2: Standard Operating Procedures (SOPs): The Blueprint for Safety and Excellence
Begin self-paced component package.
Begin self-paced component package.
Post Education Survey
8 Questions
8 Questions Sterile Compounding Designated Person Certificate Program: Unit 2: Standard Operating Procedures (SOPs): The Blueprint for Safety and Excellence On Demand, 0.75 CE JA4008389-0000-25-235-H07-P&T & 203344935
Required to Claim CE
Up to 0.75 medical credits available  |  Certificate available
Up to 0.75 medical credits available  |  Certificate available **PHARMACISTS & PHARMACY TECHNICIANS MUST SELECT THE BLUE "CLAIM CREDIT" BUTTON & ENTER YOUR DOB IN ORDER TO RECEIVE CE CREDIT** ________________________________________________________________________________________________________________________________________________________________________ NHIA adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, panelists, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Please note that the certificates printed from this platform are invalid as proof of continuing education (CE). For official documentation of CE credits, please print a paper statement of credit from your NABP e-profile.